Skip to main content
. 2022 Feb 9;16(11):2260–2273. doi: 10.1002/1878-0261.13173

Table 3.

Univariate and multivariate analyses for disease‐free survival. IC, immune cell; TC, tumor cell.

Parameter Univariate analysis Multivariate analysis
HR (95% CI) P HR (95% CI) P
Age (years) 1 (0.970–1.029) 0.951
Preoperative CEA level 1 (1.000–1.002) 0.130
Chemotherapy
No 1 1
Neoadjuvant 1.99 (1.147–3.453) 0.014 1.682 (0.918–3.082) 0.093
Longest diameter of metastases (cm)
≤ 5 1
> 5 1.29 (0.604–2.749) 0.513
N‐stage
N0 1
N+ 1.38 (0.789–2.413) 0.259
Number of metastases
≤ 1 1 1
> 1 2.12 (1.214–3.688) 0.008 1.816 (0.987–3.344) 0.055
Timing of metastases
Metachronous 1
Synchronous 0.93 (0.489–1.778) 0.832
TRG
2–3 1
4–5 1.02 (0.465–2.256) 0.952
Sex
Male 1
Female 1.41 (0.817, 2.451) 0.216
Tumor sidedness
Right‐sided 1
Left‐sided (with rectum) 1.71 (0.728, 4.020) 0.218
CD3+ IF
Low 1 1
High 0.36 (0.175–0.755) 0.007 0.309 (0.145–0.657) 0.002
CD3+ stroma
Low 1
High 1.19 (0.692–2.032) 0.534
CD3+ IE
Low 1
High 0.71 (0.380–1.333) 0.288
CD8+ IF
Low 1
High 1.21 (0.688–2.133) 0.507
CD8+ stroma
Low 1
High 1.47 (0.776–2.787) 0.237
PD‐L1 TC
Low 1
High 0.80 (0.286–2.213) 0.661
PD‐L1 IC
Low 1
High 0.58 (0.335–1.020) 0.059
CD8+ IF and PD‐L1 IC

CD8low

PD‐L1low

1

CD8hi

PD‐L1hi

0.79 (0.405–1.526) 0.477

CD8hi

PD‐L1low

1.21 (0.278–5.215) 0.803

CD8low

PD‐L1hi

0.48 (0.238–0.981) 0.044
FOXP3 IF
Staining 0 1
Staining 1 0.66 (0.313–1.412) 0.288
FOXP3 stroma
Staining 0 1
Staining 1 0.59 (0.263–1.301) 0.188
Staining 2 0.57 (0.138–2.356) 0.437
PD‐1 IF
Low 1
High 0.49 (0.192–1.264) 0.141
PD‐1 stroma
Low 1
High 0.57 (0.138–2.351) 0.437

Bold values indicate significance of P < 0.05.